Key facts
- It has raised $3.6M; the latest was Seed Round ($3.1M) in Nov 2025.
- Notable investors include Y Combinator, Standard Partners, Justin Hamilton, Multifaceted Capital, N1 (Prague) — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Novoflow
- ·The full record, as it builds
Funding rounds
No funding rounds for Novoflow are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Novoflow
Developer of an artificial intelligence (AI) platform designed to automate phone calls for medical clinics. The company's platform automates front and back office phone workflows for medical practices, sends follow-ups via text and email to ensure patients are prepared and reduce no-shows, automatically calls patients on waiting lists when appointments become available and reduce empty appointment slots, maximizes provider utilization, and saves cost, enabling clinics to effectively manage their appointments over the phone and reduce manual work.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2025
- Employees
- 5
- Website
- novoflow.io/
- Ownership
- Privately Held (backing)
Novoflow doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Novoflow shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Novoflow in its N-PORT filings yet. We sweep new filings monthly.